Skip to main content

Revance Therapeutics, Inc.

RVNCDelisted Feb 6, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001479290

Revance Therapeutics, Inc. was delisted on Feb 6, 2025; its insiders filed their last Form 4 on Feb 6, 2025; 174 institutions reported holding it in 13F filings for Q4 2024, worth $249.2M in total; Fairfax Financial was the only superinvestor holding it.

13F holders, Q3 2024

Institutional positions in Revance Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
201
+29 vs. Q2 2024
Shares held
82.9M
+10.0M (+13.8%) vs. Q2 2024
Total value
$429.9M
+$242.6M (+129.6%) vs. Q2 2024
New holders
72
39 more added
Sold out
43
55 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RVNC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 201 institutions
Q1 2021: 149 institutionsQ2 2021: 161 institutionsQ3 2021: 159 institutionsQ4 2021: 151 institutionsQ1 2022: 156 institutionsQ2 2022: 161 institutionsQ3 2022: 182 institutionsQ4 2022: 193 institutionsQ1 2023: 217 institutionsQ2 2023: 215 institutionsQ3 2023: 187 institutionsQ4 2023: 193 institutionsQ1 2024: 188 institutionsQ2 2024: 173 institutionsQ3 2024: 201 institutionsQ4 2024: 174 institutionsQ1 2025: 2 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2024: $429.9M
Q1 2021: $1.53BQ2 2021: $1.60BQ3 2021: $1.53BQ4 2021: $864.7MQ1 2022: $1.06BQ2 2022: $774.3MQ3 2022: $1.82BQ4 2022: $1.36BQ1 2023: $2.46BQ2 2023: $2.07BQ3 2023: $893.1MQ4 2023: $636.4MQ1 2024: $409.4MQ2 2024: $209.3MQ3 2024: $429.9MQ4 2024: $249.2MQ1 2025: $425.0KQ2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding RVNC and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20252$425.0K
Q4 2024174$249.2M
Q3 2024201$429.9M
Q2 2024173$209.3M
Q1 2024188$409.4M
Q4 2023193$636.4M
Q3 2023187$893.1M
Q2 2023215$2.07B
Q1 2023217$2.46B
Q4 2022193$1.36B
Q3 2022182$1.82B
Q2 2022161$774.3M
Q1 2022156$1.06B
Q4 2021151$864.7M
Q3 2021159$1.53B
Q2 2021161$1.60B
Q1 2021149$1.53B

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Revance Therapeutics, Inc.; share changes are against Q2 2024.

Institutions holding RVNC in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.8,727,584$45.3M0.00%+8,727,584New
Capital World Investors0$00.00%−13,938,589−100.0%Sold out
Polar Capital Holdings Plc0$00.00%−3,567,139−100.0%Sold out
Rubric Capital Management LP0$00.00%−2,656,847−100.0%Sold out
Bamco Inc0$00.00%−1,023,663−100.0%Sold out
Rhenman & Partners Asset Management AB0$00.00%−701,707−100.0%Sold out
Perceptive Advisors LLC0$00.00%−600,000−100.0%Sold out
EULAV Asset Management0$00.00%−500,000−100.0%Sold out
Integral Health Asset Management, LLC0$00.00%−500,000−100.0%Sold out
Graham Capital Management, L.P.0$00.00%−417,161−100.0%Sold out
CM Management, LLC0$00.00%−400,000−100.0%Sold out
UBS Oconnor LLC0$00.00%−325,314−100.0%Sold out
Lane Generational LLC0$00.00%−319,322−100.0%Sold out
Moore Capital Management, LP0$00.00%−250,000−100.0%Sold out
Citadel Advisors LLC0$00.00%−249,029−100.0%Sold out
Ghost Tree Capital, LLC0$00.00%−225,000−100.0%Sold out
Assenagon Asset Management S.A.0$00.00%−198,846−100.0%Sold out
PDT Partners, LLC0$00.00%−197,049−100.0%Sold out
Nebula Research & Development LLC0$00.00%−144,365−100.0%Sold out
Silicon Valley Capital Partners0$00.00%−135,788−100.0%Sold out
Tejara Capital Ltd0$00.00%−82,688−100.0%Sold out
Jacobs Levy Equity Management, Inc0$00.00%−81,579−100.0%Sold out
Mirador Capital Partners LP0$00.00%−72,355−100.0%Sold out
Stifel Financial Corp0$00.00%−66,325−100.0%Sold out
DnB Asset Management AS0$00.00%−60,229−100.0%Sold out
Suvretta Capital Management, LLC0$00.00%−58,425−100.0%Sold out
Hunting Hill Global Capital, LLC0$00.00%−57,222−100.0%Sold out
NorthRock Partners, LLC0$00.00%−50,162−100.0%Sold out
Sonora Investment Management Group, LLC0$00.00%−20,727−100.0%Sold out
Teacher Retirement System of Texas0$00.00%−21,694−100.0%Sold out
Principal Financial Group Inc0$00.00%−18,375−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−17,100−100.0%Sold out
HighPoint Advisor Group LLC0$00.00%−11,157−100.0%Sold out
Sherbrooke Park Advisers LLC0$00.00%−15,399−100.0%Sold out
Fairhaven Wealth Management, LLC0$00.00%−14,859−100.0%Sold out
Nottingham Advisors, Inc.0$00.00%−11,979−100.0%Sold out
GTS Securities LLC0$00.00%−10,908−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−10,300−100.0%Sold out
United Capital Financial Advisers, LLC0$00.00%−10,193−100.0%Sold out
Scotia Capital Inc.0$00.00%−10,000−100.0%Sold out
Canada Pension Plan Investment Board0$00.00%−7,700−100.0%Sold out
Huntington National Bank0$00.00%−175−100.0%Sold out
Bell Investment Advisors, Inc0$00.00%−126−100.0%Sold out
Toronto Dominion Bank0$00.00%−5−100.0%Sold out
BlackRock Inc.––––Not filed